Stock search

Ticker or company name

Compare stocks

Market: US

  • BDXBecton Dickinson
  • BSXBoston Scientific
  • EWEdwards Lifesciences

Add stock

Ticker or company

Summary

BDX
Becton Dickinson
$216,47Down −0,72%
Year: Up +44%
38/100Ratio would not consider buying
Open stock page
BSX
Boston Scientific
$43,69Down −1,47%
Year: Down −58%
83/100Best scoreRatio would consider buying
Open stock page
EW
Edwards Lifesciences
$107,11Down −0,04%
Year: Up +24%
56/100Ratio would watch
Open stock page

Verdict

BSX has the best score (83). EW grows revenue the fastest. BSX is the cheapest by forward P/E. EW has the lowest debt load. BSX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckBDX2 ✓ 2 — 4 ✕BSX6 ✓ 3 — 0 ✕EW5 ✓ 0 — 4 ✕
P/E vs its history51,818,460,3
P/E vs industry51,818,460,3
Forward P/E14,914,035,5
Revenue growth, YoY−2,6%+8,9%+13,4%
EPS growth, YoY−39,4%+26,2%−23,7%
Net margin4,5%16,6%15,2%
Net debt / EBITDA2,9−0,1−2,5
Free cash flown/a—$3,33 bn$1,42 bn
Share count over a year−4,2%−2,9%−1,4%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBDXTTMBSXTTMEWTTMIndustry medianTTM
P/E TTM ↓51,8Best: 18,4Worst: 60,325,1
Forward P/E ↓14,9Best: 14,0Worst: 35,516,2
PEG ↓−27,10,7n/a2,2
P/S TTM ↓Best: 2,93,1Worst: 9,22,2
EV/EBITDA ↓16,4Best: 15,6Worst: 43,817,3
P/FCF ↓21,5Best: 19,3Worst: 42,619,5

Price, %

  • BDXn/a
  • BSXn/a
  • EWn/a

Returns

Best WorstNo mark — in between

PeriodBDXBSXEW
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BDXBSXEW
Share of “buy”Worst: 57%65%Best: 82%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 3 of 4
Average “surprise”Best: +2,2%+1,5%Worst: +0,7%
Insiders over 12 monthssales $3,38 msales $6,76 msales $34,0 m

Details are on each stock page.